on December 28, 2006
Published online before print December 28, 2006, doi: 10.1161/01.ATV.0000256458.82320.be
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 4, 2006
Accepted on November 19, 2006
In Vivo Actions of Angiopoietins on Quiescent and Remodeling Blood and Lymphatic Vessels in Mouse Airways and Skin
Kyung Eun Kim ;
From the National Research Laboratory of Vascular Biology and Department of Biological Sciences (K.E.K., C-H.C., H-Z.K., G.Y.K.), Korea Advanced Institute of Science and Technology, Daejeon, Korea; Cardiovascular Research Institute (P.B., D.M.M.), Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, Calif.
* To whom correspondence should be addressed. E-mail: gykoh{at}kaist.ac.kr.
Objective--We investigated and compared the in vivo effects of all four angiopoietins (COMP-Ang1, Ang2, Ang3, and Ang4) on blood and lymphatic vascular remodeling in adult mice. We analyzed the microvasculature of trachea and ear skin, and compared quiescent skin microvasculature with that during wound healing.
Methods and Results--We were able to achieve similar levels of relatively long-term and sustained circulating expression of each angiopoietin using an adenoviral delivery system. Two weeks after treatment, we observed tracheal blood and lymphatic vascular enlargement, and lymphatic filopodia formation, with the following order of potency: COMP-Ang1>Ang3=Ang4>Ang2. Co-treatment with Ang2 attenuated Ang1-induced tracheal blood and lymphatic remodeling. In the normal ear skin, all angiopoietins induced blood vessel enlargement, whereas none induced lymphatic vascular remodeling. However, in the healing margin of ear skin wounds, all angiopoietins strongly induced lymphatic vascular enlargement and formation of lymphatic sprouts and filopodia, while they potentiated blood vascular enlargement. Co-treatment of Ang2 with Ang1 produced an additive effect on these changes.
Conclusion--This study, one of the first to our knowledge to characterize the in vivo actions of all 4 angiopoietins, may expand the current concepts for use of angiopoietins for therapeutic angiogenesis and lymphangiogenesis.
Key words: angiogenesis • angiopoietin • lymphangiogenesis • Tie2 • vascular remodeling
This article has been cited by other articles:
 |
|
 |
|
  B. L. Falcon, H. Hashizume, P. Koumoutsakos, J. Chou, J. V. Bready, A. Coxon, J. D. Oliner, and D. M. McDonald Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels Am. J. Pathol., November 1, 2009; 175(5): 2159 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, N. Song, Y. Ding, S. Yuan, X. Li, H. Cai, H. Shi, and Y. Luo Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis Cancer Res., October 1, 2009; 69(19): 7529 - 7537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Winnik, M. Klinkert, H. Kurz, C. Zoeller, J. Heinke, Y. Wu, C. Bode, C. Patterson, and M. Moser HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2 Cardiovasc Res, August 1, 2009; 83(3): 558 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Winderlich, L. Keller, G. Cagna, A. Broermann, O. Kamenyeva, F. Kiefer, U. Deutsch, A. F. Nottebaum, and D. Vestweber VE-PTP controls blood vessel development by balancing Tie-2 activity J. Cell Biol., May 18, 2009; 185(4): 657 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jang, Y. J. Koh, N. K. Lim, H. J. Kang, D. H. Kim, S. K. Park, G. M. Lee, C. J. Jeon, and G. Y. Koh Angiopoietin-2 Exocytosis Is Stimulated by Sphingosine-1-Phosphate in Human Blood and Lymphatic Endothelial Cells Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 401 - 407. [Abstract] [Full Text] [PDF]
|
|